It appears that our website is not compatible with your browser.
Please use one of the following browsers to have the best website experience:
Chrome 52+, Firefox 47+, Edge 25+, Safari 9.1.2+, IE11
If IE11 does not work please check your "Compatibility Settings" and follow the instructions below:
1. Open up Internet Explorer (IE 11)
2. Press the Alt key on your keyboard, this will make a menu bar appear.
3. Click on the Tools menu tab.
4. Select the Compatibility View settings option.
5. Uncheck the "Display intranet sites in Compatibility View" option
6. Make sure to remove beaconlbs.com site from the Websites you've added to Compatibility View list
/ October 16, 2019 / by beaconlbs
Featured Lab-Of-Choice: GeneDx
BeaconLBS has invited the Labs-of-Choice™ to provide some more information about themselves for a blog series featuring each of the Labs-of-Choice. The following content was provided by the featured lab, GeneDx.
Company Description: Rare Genetics Laboratory
GeneDx was founded in 2000 by two scientists from the National Institutes of Health (NIH) to diagnose patients with rare disorders and assist clinicians responsible for treating these patients. GeneDx has become a global industry leader in genetics and genomics, having provided testing to patients and their families in over 55 countries.
Led by its clinical genomics program, and a comprehensive genetic testing menu, GeneDx offers genetic testing for hereditary cancers, cardiac, mitochondrial, rare and neurological disorders, prenatal diagnostics, and targeted variant testing. To date, GeneDx has performed over 150,000 exomes. www.genedx.com
You Might Also Like:
Global Lab Testing / October 15, 2020 / by beaconlbs
It is vital, as new discoveries are made in cardiac biomarkers, that well-designed studies that provide clinical validity and utility are published.
Molecular Genetics / June 11, 2019 / by beaconlbs
Recently, there has been much excitement about the potential for liquid biopsy’s possible applications in cancer detection, diagnosis, and treatment. Learn more about the current evidence of clinical utility of cell free DNA in our latest blog.